Sire Bioscience Inc. is a listed company. Filings by its managers are published through SEDI. No insider at Sire Bioscience Inc. has published a filing in the past twelve months. The most recent one dates from 9 April 2021.
Looking back to 2019, when coverage begins, insiders filed 18 purchases and no sales.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 31 declarations
Sire Bioscience Inc. is a company listed on the Toronto Stock Exchange, specializing in the biotechnology sector. It focuses on developing products related to cannabis and health.